Company / EPS (Basic)
AbbVie EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.73
FY2025
5-year range
$2.73 / $6.65
FY2021-FY2025
Trend
-58.9%
vs FY2024
Sector context
#17 of 208
Health Care
What the data says
Among 208 Health Care companies, AbbVie is in the top 8% for eps (basic). EPS (Basic) has fluctuated over the past 10 years, ranging from $1.11 in FY2016 to $6.65 in FY2024.
Based on SEC 10-K filings.
2.73 in FY2025 with a 5-year CAGR of -5.7%. Top quartile in the Health Care sector.
Declined from $6.48 to $2.73 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 208This company $2.73 Sector average -$1.02
▼
+368.7% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 58.9% year-over-year.
- Ranks #17 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2024.
- Lowest eps (basic) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.73 | -58.9% |
| FY2024 | $6.65 | +2.6% |
| FY2023 | $6.48 | +137.4% |
| FY2022 | $2.73 | -48.5% |
| FY2021 | $5.30 | +44.4% |
| FY2020 | $3.67 | +10.9% |
| FY2019 | $3.31 | -9.3% |
| FY2018 | $3.65 | +15.9% |
| FY2017 | $3.15 | +183.8% |
| FY2016 | $1.11 | -57.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026